Search
Close this search box.
Search
Subscriber Log In

THOUGHT LEADERSHIP

Catch up with our insights on the big issues in pharma.

Our thought leadership library brings you our latest data-driven reports, infographics and articles that tackle the big issues, interesting niches and everything in between.

Latest Content

A Digital Health Innovation Report by Galen Growth, powered by HealthTech Alpha
As part of Evaluate’s partnership with Galen Growth, we bring you their latest report on Digital Health Innovation in US Health Systems, built using data from HealthTech Alpha. In the vast and complex US healthcare system, it’s challenging for all types...
Read More
Banner-Galen-Growth-Report
EVALUATING: Neurology
Neurology is experiencing a resurgence, highlighted by increased deal activity, clinical advancements and a notable IPO. This revival, though less conspicuous than obesity’s, emerges from years of underinvestment, resulting in a landscape filled...
Read More
Biopharma-2022-Whats-Next-featured-image
Antibody Drug Conjugates Report
Antibody-drug conjugates (ADCs) are the hottest real estate in oncology, attracting billions from big pharma: Pfizer acquired Seagen for $43 billion AbbVie invested over $10 billion in ImmunoGen Merck committed $4 billion upfront, with a potential total...
Read More
Antibody-Drug-Conjugates-Report-featured-image
More content

Featured Contributors